Similar Articles
111 Loss-of-function mutations of microRNA-142-3p promote ASH1L expression to induce immune evasion and hepatocellular carcinoma progression
112 Prognostic value of preoperative systemic immune-inflammation index/albumin for patients with hepatocellular carcinoma undergoing curative resection
113 N6-methyladenosine-modified long non-coding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression
114 Landscape of transarterial chemoembolization represented interventional therapy for hepatocellular carcinoma
115 Targeting hypoxia and angiogenesis in hepatocellular carcinoma: New insights and therapeutic strategies
116 Role of a new inflammation predictor in predicting recurrence of atrial fibrillation after radiofrequency catheter ablation
117 Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization
118 Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
119 Hepatocellular carcinoma national burden across different geographical regions in the United States between 2001 and 2020
120 Imaging-based prediction of hepatocellular carcinoma recurrence after microwave ablation as bridge therapy: A glimpse into the future
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA